Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas

<p>BACKGROUND AND OBJECTIVES: Radionuclide therapy has been used to treat patients with progressive/metastatic paragangliomas (PGLs) and phaeochromocytomas (PCCs). The aim of the present study is to retrospectively compare the therapeutic outcomes of these modalities in patients with progressi...

Full description

Bibliographic Details
Main Authors:	Nastos, K, Cheung, V, Toumpanakis, C, Navalkissoor, S, Quigley, A, Caplin, M, Khoo, B
Format:	Journal article
Language:	English
Published:	Wiley 2017

Similar Items

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
by: Kaltsas, G, et al.
Published: (2003)

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of <sup>131</sup>I-MIBG
by: Ezziddin Samer, et al.
Published: (2012-01-01)

MIBG scans for phaeochromocytoma: time to abandon the technique?
by: Grossman, A, et al.
Published: (2009)

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
by: Bomanji, J, et al.
Published: (1993)

Precision Medicine in Phaeochromocytoma and Paraganglioma
by: Bettina Winzeler, et al.
Published: (2021-11-01)

The clinical genetics of phaeochromocytoma and paraganglioma
by: P. T. Kavinga Gunawardane, et al.

Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.
by: Mihai, R, et al.
Published: (2008)

Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review
by: Stefan Prado-Wohlwend, et al.
Published: (2022-10-01)

Evaluation of 99mTc-HYNIC-TOC and 131I-MIBG imaging in diagnosis of pheochromocytoma and paraganglioma
by: WANG Yu, TONG Anli, ZHOU Yue, ZHANG Wenqian, CUI Yunying, JING Hongli , LI Yuxiu
Published: (2024-03-01)

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
by: Chrisoulidou, A, et al.
Published: (2007)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
by: Bouloux, P, et al.
Published: (1986)

Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
by: U. Srirangalingam, et al.
Published: (2017-01-01)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
by: Calum Urquhart, et al.
Published: (2022-11-01)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
by: Foo, S.H., et al.
Published: (2010)

A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
by: Christopher S. Boot
Published: (2023-09-01)

[177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center
by: Stefan Prado-Wohlwend, et al.
Published: (2022-02-01)

Radioterapia interna con metayodobencilguanidina 131I-MIBG
by: Harold Machado, et al.
Published: (2002-07-01)

Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)
by: Armaghan Fard-fahani, et al.
Published: (2011-09-01)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
by: Bhatia, K, et al.
Published: (2008)

تهیّه کیت [I131] متا یُدو بنزیل گوانیدین (MIBG- I131)
by: علی ستاری
Published: (2004-02-01)

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
by: Camilo Jimenez, et al.
Published: (2019-07-01)

Sequelae and survivorship in patients treated with 131 I-MIBG therapy
by: Sze, W, et al.
Published: (2013)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
by: Sze, W, et al.
Published: (2013)

131I-MIBG myocardial scintigraphy in patients with Parkinson's disease
by: Tuan-feng YANG, et al.
Published: (2016-06-01)

Predictors of outcome in phaeochromocytomas and paragangliomas [version 1; referees: 3 approved]
by: Marlo Nicolas, et al.
Published: (2017-12-01)

Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1
by: A Al-Sharefi, et al.
Published: (2018-10-01)

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy
by: Li WANG, et al.
Published: (2014-03-01)

Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
by: Antonella Lucia Marretta, et al.
Published: (2023-02-01)

Peptide receptor radionuclide therapy in advanced Pheochromocytomas and Paragangliomas: a systematic review and meta-analysis
by: Dan Su, et al.
Published: (2023-07-01)

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
by: Samsudin, Intan Nureslyna, et al.
Published: (2018)

Identification of Novel Mutations and Expressions of <i>EPAS1</i> in Phaeochromocytomas and Paragangliomas
by: Farhadul Islam, et al.
Published: (2020-10-01)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
by: Poplawski NK, et al.
Published: (2012-04-01)

PEMBUATAN SENYAWA BERTANDA 131I-MIBG DENGAN PENINGKATAN DOSIS TERAPI
by: Maskur Maskur, et al.
Published: (2021-02-01)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
by: Lawrence, J, et al.
Published: (2004)

Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
by: Hiroshi Wakabayashi, et al.
Published: (2019-06-01)

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
by: Kaltsas, G, et al.
Published: (2004)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
by: Srirangalingam, U, et al.
Published: (2008)

RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS
by: Shaunak Navalkissoor, et al.
Published: (2015-11-01)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
by: Astuti, D, et al.
Published: (2003)